GR3007402T3 - - Google Patents

Info

Publication number
GR3007402T3
GR3007402T3 GR930400553T GR930400553T GR3007402T3 GR 3007402 T3 GR3007402 T3 GR 3007402T3 GR 930400553 T GR930400553 T GR 930400553T GR 930400553 T GR930400553 T GR 930400553T GR 3007402 T3 GR3007402 T3 GR 3007402T3
Authority
GR
Greece
Prior art keywords
quinoxalinones
quinoxalinone
alkoxyphenyl
alkylphenyl
bromophenyl
Prior art date
Application number
GR930400553T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3007402T3 publication Critical patent/GR3007402T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
GR930400553T 1986-10-30 1993-03-18 GR3007402T3 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1986/002335 WO1992005160A1 (en) 1986-10-30 1986-10-30 4-arylsulfonyl-3,4-dihydro-2(1h)-quinoxalinone-1-alkanoic acids, esters, and salts

Publications (1)

Publication Number Publication Date
GR3007402T3 true GR3007402T3 (en:Method) 1993-07-30

Family

ID=22195697

Family Applications (1)

Application Number Title Priority Date Filing Date
GR930400553T GR3007402T3 (en:Method) 1986-10-30 1993-03-18

Country Status (11)

Country Link
US (1) US4940708A (en:Method)
EP (1) EP0266102B1 (en:Method)
JP (1) JPS63295566A (en:Method)
AT (1) ATE86985T1 (en:Method)
DE (1) DE3784835T2 (en:Method)
DK (1) DK561487A (en:Method)
ES (1) ES2046206T3 (en:Method)
GR (1) GR3007402T3 (en:Method)
IE (1) IE68851B1 (en:Method)
PT (1) PT85998B (en:Method)
WO (1) WO1992005160A1 (en:Method)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992005160A1 (en) * 1986-10-30 1992-04-02 Reinhard Sarges 4-arylsulfonyl-3,4-dihydro-2(1h)-quinoxalinone-1-alkanoic acids, esters, and salts
ES2164639T3 (es) * 1991-04-15 2002-03-01 Aventis Pharma Gmbh Quinoxalinas, procedimiento para su preparacion y su empleo.
US6369057B1 (en) 1991-04-15 2002-04-09 Aventis Pharma Deutschland Gmbh Quinoxalines, processes for their preparation and their use
US7351709B2 (en) 2004-06-09 2008-04-01 Wyeth Estrogen receptor ligands
CN101296910A (zh) * 2005-08-26 2008-10-29 梅特希尔基因公司 组蛋白脱乙酰酶的苯并二氮杂卓和苯并哌嗪类似物抑制剂
NZ609829A (en) 2008-04-30 2014-06-27 Xyleco Inc Processing biomass
US7867358B2 (en) 2008-04-30 2011-01-11 Xyleco, Inc. Paper products and methods and systems for manufacturing such products
US8212087B2 (en) 2008-04-30 2012-07-03 Xyleco, Inc. Processing biomass
US8236535B2 (en) 2008-04-30 2012-08-07 Xyleco, Inc. Processing biomass
KR20180126092A (ko) 2008-10-28 2018-11-26 질레코 인코포레이티드 탄화수소-함유 재료의 처리방법
US20240000806A1 (en) * 2020-11-20 2024-01-04 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods and materials for inhibiting cb1 activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4209527A (en) * 1979-05-16 1980-06-24 Pfizer Inc. Benzimidazolone derivatives
WO1992005160A1 (en) * 1986-10-30 1992-04-02 Reinhard Sarges 4-arylsulfonyl-3,4-dihydro-2(1h)-quinoxalinone-1-alkanoic acids, esters, and salts

Also Published As

Publication number Publication date
ATE86985T1 (de) 1993-04-15
IE872877L (en) 1988-04-28
EP0266102A2 (en) 1988-05-04
JPS63295566A (ja) 1988-12-01
WO1992005160A1 (en) 1992-04-02
US4940708A (en) 1990-07-10
DK561487D0 (da) 1987-10-27
EP0266102B1 (en) 1993-03-17
DK561487A (da) 1988-08-08
DE3784835D1 (de) 1993-04-22
IE68851B1 (en) 1996-07-24
PT85998B (pt) 1990-08-31
ES2046206T3 (es) 1994-02-01
PT85998A (en) 1987-11-01
JPH0536436B2 (en:Method) 1993-05-31
EP0266102A3 (en) 1989-11-23
DE3784835T2 (de) 1993-06-24

Similar Documents

Publication Publication Date Title
DK0379979T3 (en:Method)
NO905572L (no) Fremgangsmaate for fremstilling av peptidforbindelser.
AU635758B2 (en) Thiazole derivatives, processes for production thereof and pharmaceutical compositions comprising the same
DK57388D0 (da) Thiazolidinonderivater, fremgangsmaade til deres fremstilling samt anvendelsen heraf
GR3007402T3 (en:Method)
AU657106B2 (en) Preparation and use of N-iodopropargyl oxycarbonyl amino acid esters and derivatives as antimicrobial agents
ES2103931T3 (es) Imidazoacridinas y su uso antineoplasico.
DK0401981T3 (da) Pyridazinonderivater
MY106552A (en) Novel pyrido[2,3-f] [1,4]thiazepines and pyrido[3,2-b] [1,5] benzothiazepines.
WO1999004770A3 (en) A pharmaceutical composition active in reducing production of mcp-1 protein
GB8706662D0 (en) Anti-arrhythmia agents
NO903211D0 (no) Salter av n5,n10-metylen-5-6-7-8-tetrahydrofolsyre samt fremgangsmaate for deres fremstilling.
ES8704881A1 (es) Un procedimiento para la preparacion de anilidas de acidos arilaceticos sustituidos.
BE895712A (fr) Derives de benzo-1,3-thiazine-1,1-dixoyde, leur preparation et leur utilisation
EP0176049A3 (en) Aminoalkylnaphtalene derivatives having pharmacological activities
AU4084889A (en) Antihypertensive 3-piperidinyl-indazole derivatives
FI862634A0 (fi) Spiro-heteroazaloner foer vaord av komplikationer vid diabetes.
DE3766028D1 (de) 1-hydroxy-5-oxo-5h-pyrido(3,2-a)-phenoxazin-3-carbonsaeureester.
CA1270833C (en) 2,5-PYRROLIDINEDIONE DERIVATIVES USEFUL AS ANTI-ARHYTMIZING AGENTS
AU3943989A (en) Antiinflammatory carbinoloimidazoles